In the majority of cases, CFCS is caused by de novo activating mutations in BRAF (MIM *164757), encoding a serine/threonine protein kinase functioning as a RAS effector [10,11]. The gene discussed is BRAF; the disease is cardiofaciocutaneous syndrome 1.